From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Futura Medical: Trump Tariffs the excuse with the next warning?

By Tom Winnifrith | Friday 11 April 2025


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Who knows what the Orange man will say or do next? I do not claim to know but it is clear that the tariff war is causing both businesses and consumers to defer or change purchasing patterns. A number of companies with exposure to the US have already withdrawn earnings guidance. For Futura Medical (FUM), producer of Eroxon, an ED product that does not seem to work very well, the US is a key market.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Thursday »

HAYD

Haydale – US disaster……Oh Dear!

Wednesday »

Gold

As Gold Battles $3,300, What For The Miners?

 

BOOM

Evil’s Rule: Audioboom

 

URU…Who R U Kidding?

Sunday »

EZJ

BUY Easyjet

Time left: 09:18:57